Withuspharmaceutical Co.Ltd (330350.KQ) stock: key figures, P/E, revenue and dividend
Energy · Coal & Consumable Fuels · South Korea
Withuspharmaceutical Co.Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 102.72 bn KRW | 106.44 bn KRW |
| Gross profit | 65.55 bn KRW | 68.83 bn KRW |
| Operating income | 5.46 bn KRW | 5.66 bn KRW |
| EBIT | 5.95 bn KRW | 5.23 bn KRW |
| Net income | 4.78 bn KRW | 4.97 bn KRW |
| Diluted EPS – continuing operations | 362.49 KRW | 376.31 KRW |
Full history since 2017, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Withuspharmaceutical Co.Ltd
WITHUS PHARMACEUTICAL Co.,LTD. engages in the production and sale of pharmaceutical products in South Korea. It offers circulatory agents, endocrine cost medications, osteoporosis treatment products, antithrombotic medicines, central nervous system agents, digestive tract medications, respiratory/skin preparations, musculoskeletal medications, antibiotics, antifungal and antiviral drugs, genitourinary tract medications, psychotropic agents, and other products. The company was previously known as Withers Medipharm Co. , Ltd. and changed its name to WITHUS PHARMACEUTICAL Co.,LTD. in October 2007. WITHUS PHARMACEUTICAL Co.,LTD. was founded in 2004 and is headquartered in Seoul, South Korea.
More stocks
- C-Media Electronics (6237.TWO)
- Siamrajathanee Public Company Limited (SO.BK)
- Chumporn Palm Oil Industry Public Company Limited (CPI.BK)
- Sumeeko Industries Co Ltd (2066.TWO)
- SUI Group Holdings Ltd. (SUIG)
- Powertech Industrial Co Ltd (3296.TW)
- Drilling Tools International Corp (DTI)
- Aquila European Renewables Income PLC (AERI.L)
- Cape EMS Berhad (5311.KL)
- Grupe S.A.B. de C.V (CIDMEGA.MX)
- BCP Investment Corp (BCIC)
- Ecograf Ltd (EGR.AX)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.